Literature DB >> 35116772

A mechanism of regucalcin knock-down in the promotion of proliferation and movement of human cervical cancer HeLa cells.

Xiaolong Li1,2, Yingwen Huang3, Pengfei Wang2, Wei Song2, Qingmei Yao2, Qiping Hu1, Sufang Zhou2,4.   

Abstract

BACKGROUND: Regucalcin (RGN) has been reported to have inhibitory effects on the proliferation and migration of many cancer cells. In this research, RGN expression has been silenced to study its effects on human cervical cancer HeLa cells.
METHODS: Lentivirus mediated siRNA was infected into HeLa cells by lentivirus vector. The RGN expression was measured by quantitative real-time PCR (RT-qPCR) and Western blotting (WB). Cell count kit-8, colony formation assay and transwell assay were used to detect cell proliferation, migration and invasion. The expression of Wnt/β-catenin pathway and epithelial-mesenchymal transition (EMT) related proteins, including β-catenin, GSK-3β, p-GSK-3β, matrix metalloproteinase-3 (MMP-3), matrix metalloproteinase-7 (MMP-7), matrix metalloproteinase-9 (MMP-9), E-cadherin, N-cadherin and vimentin, were detected by WB.
RESULTS: Compared with HeLa-NC cell line, the expressions of RGN and E-cadherin in HeLa-siRGN cell lines are significantly decreased, while the expressions of β-catenin, MMP-3, MMP-7, MMP-9, p-GSK-3β, N-cadherin and vimentin increased. The RGN down-regulation has been observed to promote cell proliferation, enhanced cell migration and invasion.
CONCLUSIONS: The down-regulation of RGN may enhance the activity of metastasis related signaling pathway Wnt/β-catenin and EMT in the progression of cervical cancer. 2019 Translational Cancer Research. All rights reserved.

Entities:  

Keywords:  HeLa; Regucalcin (RGN); invasion; migration; proliferation

Year:  2019        PMID: 35116772      PMCID: PMC8797288          DOI: 10.21037/tcr.2019.02.01

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN: 2218-676X            Impact factor:   1.241


  37 in total

Review 1.  Revealing the world of RNA interference.

Authors:  Craig C Mello; Darryl Conte
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 2.  Current and potential treatments for cervical cancer.

Authors:  Grace P C Yee; Paul de Souza; Levon M Khachigian
Journal:  Curr Cancer Drug Targets       Date:  2013-02       Impact factor: 3.428

3.  Inhibition of SMP30 gene expression influences the biological characteristics of human Hep G2 cells.

Authors:  Sheng-Chang Zhang; Ming-Kang Liang; Guang-Lin Huang; Kui Jiang; Su-Fang Zhou; Shuang Zhao
Journal:  Asian Pac J Cancer Prev       Date:  2014

4.  Reversible effect of calcium-binding protein on the Ca2+-induced activation of succinate dehydrogenase in rat liver mitochondria.

Authors:  M Yamaguchi; H Shibano
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-09       Impact factor: 1.645

Review 5.  The potential role of regucalcin in kidney cell regulation: Involvement in renal failure (Review).

Authors:  Masayoshi Yamaguchi
Journal:  Int J Mol Med       Date:  2015-09-11       Impact factor: 4.101

6.  MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway.

Authors:  B Song; H-X Lin; L-L Dong; J-J Ma; Z-G Jiang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-03       Impact factor: 3.507

7.  Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.

Authors:  Ningning Cong; Ping Du; Anling Zhang; Fajuan Shen; Juan Su; Peiyu Pu; Tao Wang; Jie Zjang; Chunsheng Kang; Qingyu Zhang
Journal:  Oncol Rep       Date:  2013-01-31       Impact factor: 3.906

8.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.

Authors:  Masayoshi Yamaguchi; Satoru Osuka; M Neale Weitzmann; Bassel F El-Rayes; Mamoru Shoji; Tomiyasu Murata
Journal:  Int J Oncol       Date:  2016-02-25       Impact factor: 5.650

10.  Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation.

Authors:  Xinqi Zhang; Mingxi Yang; Hua Shi; Jianxin Hu; Yuanlin Wang; Zhaolin Sun; Shuxiong Xu
Journal:  Oncotarget       Date:  2017-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.